| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.8M | — | +479.1% |
| Cost of Revenue | $2.6M | — | +449.7% |
| Gross Profit | $210K | — | +1650.0% |
| R&D Expense | $7.7M | — | -37.3% |
| SG&A Expense | $6.2M | — | +1.6% |
| Operating Income | -$13.2M | — | +32.9% |
| Net Income | -$11.7M | — | +32.0% |
| EPS (Basic) | -$0.07 | — | +30.0% |
| EPS (Diluted) | -$0.07 | — | +30.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $20.3M | -11.7% | +64.3% |
| Short-term Investments | $52.2M | -24.8% | -52.0% |
| Accounts Receivable | $3.0M | +518.8% | +52.3% |
| Inventory | $1.9M | — | — |
| Current Assets | $81.4M | -17.4% | -36.4% |
| Total Assets | $190.8M | -6.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$12.7M | — | +9.1% |
| Capital Expenditures | $1.9M | — | -74.4% |
| Investing Cash Flow | $10.1M | — | -42.7% |
| Financing Cash Flow | $0 | — | +100.0% |
| Free Cash Flow | -$14.6M | — | +31.6% |
| -20.8% |
| Current Liabilities | $8.1M | -18.1% | -12.6% |
| Total Liabilities | $9.0M | -21.8% | -30.5% |
| Stockholders' Equity | $181.7M | -5.4% | -20.3% |